These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37475874)

  • 1. Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma.
    Jiang W; Hu K; Liu X; Gao J; Zhu L
    Pathol Oncol Res; 2023; 29():1611210. PubMed ID: 37475874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the molecular feature of M2 macrophages of head and neck squamous cell carcinoma.
    Wu S; Lv X; Wei H; Wu J; Liu S; Li X; Song J; Zou C; Ai Y
    J Cell Mol Med; 2024 Mar; 28(5):e18083. PubMed ID: 38393307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.
    Hu C; Fan J; He G; Dong C; Zhou S; Zheng Y
    PLoS One; 2022; 17(6):e0269166. PubMed ID: 35653344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
    Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
    Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptors signature reveal the head and neck squamous cell carcinoma energy metabolism phenotype and clinical outcome.
    Yao Y; Wang D; Zhang Y; Tang Q; Xu Z; Qin L; Qu Y; Yan Z
    J Gene Med; 2024 Jan; 26(1):e3605. PubMed ID: 37932968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
    Chen YP; Wang YQ; Lv JW; Li YQ; Chua MLK; Le QT; Lee N; Colevas AD; Seiwert T; Hayes DN; Riaz N; Vermorken JB; O'Sullivan B; He QM; Yang XJ; Tang LL; Mao YP; Sun Y; Liu N; Ma J
    Ann Oncol; 2019 Jan; 30(1):68-75. PubMed ID: 30407504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
    Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
    Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck.
    Chen WC; Lai CH; Chuang HC; Lin PY; Chen MF
    Head Neck; 2017 Feb; 39(2):347-355. PubMed ID: 27696591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of immune cell content in tumor using single-cell RNA-seq reference data.
    Yu X; Chen YA; Conejo-Garcia JR; Chung CH; Wang X
    BMC Cancer; 2019 Jul; 19(1):715. PubMed ID: 31324168
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cells in head and neck squamous cell carcinoma.
    He JY; Huo FY; Tang HC; Liu B; Bu LL
    Int Rev Cell Mol Biol; 2023; 375():33-92. PubMed ID: 36967154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
    Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
    Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of
    Zhang P; Zhao Y; Xia X; Mei S; Huang Y; Zhu Y; Yu S; Chen X
    Oncoimmunology; 2023; 12(1):2203073. PubMed ID: 37089448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq.
    Tian Y; Liu C; Yang W; Li X; Zhang M; Xiong Y; Ren X; Ma Z; Jin X; Wu Y; Dong X; Hu N; Xie Z; Qin Y; Wu S
    Cancer Immunol Immunother; 2024 Aug; 73(10):187. PubMed ID: 39093451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
    Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X
    J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review on the current knowledge and use of single-cell RNA sequencing in head and neck cancer.
    Stampe H; Jakobsen KK; Bendtsen SK; Grønhøj C; von Buchwald C
    APMIS; 2021 Nov; 129(11):619-625. PubMed ID: 34561896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase.
    Savardekar H; Allen C; Jeon H; Li J; Quiroga D; Schwarz E; Wu RC; Zelinskas S; Lapurga G; Abreo A; Stiff A; Shaffer J; Blaser BW; Old M; Wesolowski R; Xin G; Kendra KL; Chung D; Carson WE
    Mol Cancer Res; 2024 Mar; 22(3):308-321. PubMed ID: 38015751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment.
    Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ
    Front Immunol; 2022; 13():975847. PubMed ID: 36091055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
    Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
    Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.